相关实验视频
Updated: Jan 18, 2026

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.2K
肉病对肉瘤患者的影响:系统性审查和元分析
Domenico Albano1,2, Moreno Zanardo3, Mariachiara Basile4
1IRCCS Istituto Ortopedico Galeazzi, 20161, Milan, Italy.
La Radiologia medica
|June 3, 2025
概括
肉症是一种肌肉损失的情况,与肉患者的病情恶化有关. 这项元分析发现,肉患者面临着91%更高的死亡风险,这凸显了进一步研究的必要性.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 老年病的医生 老年病的医生
背景情况:
- 萨科佩尼亚与各种癌症的不良结果有关.
- 特别是对肉 Sarcoma 患者的肉 Sarcopenia 的预后影响需要澄清.
研究的目的:
- 通过CT扫描评估的肉类症对肉类患者预后的影响,系统地审查和元分析.
- 为了评估 sarcopenia 和总生存率 (OS) 和无复发生存率 (RFS) 在肉瘤之间的关联.
主要方法:
- 在PubMed,Embase和SCOPUS数据库中进行了全面的搜索.
- 来自18项涉及1699名患者的研究的数据进行了元分析.
- 对OS和RFS计算了危险比率 (HR) 和95%置信区间 (CI).
主要成果:
- 麻性肉瘤患者的死亡风险显著增加 (汇总HR=1.91,p<0.01).
- 萨尔科佩尼亚和无复发存活率之间没有发现显著的关联 (合并HR=1.16,p=0.28).
- 脂肉瘤是最常见的组织型,化疗是主要干预措施.
结论:
- 肉症与肉瘤患者的较差结果有关,特别是在整体生存期方面.
- 对OS和RFS的确切影响需要使用标准化方法进行进一步调查.
- 这项研究协议已注册在PROSPERO (CRD42024578969) 中.
相关概念视频
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K

